Table 1.
Patient Characteristics at Most Recent Visit
| Transgender women % (N) | Transgender men % (N) | |
|---|---|---|
| N | 2509 | 1893 |
| Median age (range) | 30 (20, 70) | 26 (20, 67) |
| Median BMI (kg/m2) (range) | 26.4 (12.9, 66) | 27.6 (14.2, 67.9) |
| Underweight (≤18.5) | 4.0% (99) | 1.6% (31) |
| Normal (18.6–25) | 37.3% (936) | 31.8% (602) |
| Overweight (25.1–30) | 27.0% (678) | 27.7% (525) |
| Obese (30.1–40) | 24.7% (620) | 28.1% (533) |
| Class 3 Obese (≥40) | 7.0% (176) | 10.7% (203) |
| Sexual orientation | ||
| Gay/Lesbian | 24.4% (611) | 12.3% (233) |
| Bisexual | 20.1% (503) | 10.6% (200) |
| Queer | 12.8% (320) | 34.3% (650) |
| Straight | 20.3% (509) | 23.8% (450) |
| Other | 22.6% (566) | 19.0% (360) |
| Race | ||
| White | 54.9% (1377) | 66.0% (1250) |
| Black | 18.6% (466) | 12.5% (236) |
| Latinx | 17.9% (448) | 13.5% (256) |
| Other | 8.7% (218) | 8.0% (151) |
| Insurance status | ||
| Private | 42.7% (1072) | 58.5% (1107) |
| Medicare | 5.4% (135) | 2.0% (37) |
| Medicaid | 26.2% (656) | 16.7% (316) |
| Sliding scale | 25.8% (646) | 22.9% (433) |
| HIV | 13.4% (336) | 0.7% (13) |
| Diabetes | 3.3% (83) | 3.0% (56) |
| Median year since first hormone prescription (range) | 2.6 (0.5, 12.0) | 2.2 (0.5, 11.9) |
| Ever smoker (missing=747) | 38.9% (804) | 37.9% (602) |
| Mean total cholesterol mg/dL (SD) (missing=378) | 173.3 (36.3) | 173.2 (37.0) |
| Ever use estrogen | 99.0% (2485) | 8.0% (152) |
| Ever use AA | 94.2% (1364) | 4.6% (87) |
| Ever use progestin | 29.8% (748) | 2.8% (53) |
| Ever use testosterone | 1.6% (41) | 99.6% (1886) |
AA, androgen antagonist; BMI, body mass index; SD, standard deviation.